版本:
中国

BRIEF-Redhill Biopharma says U.S. District court granted Concordia unit treble damages

March 7 Redhill Biopharma Ltd

* Redhill Biopharma - U.S. District court granted Concordia unit treble damages related to false claims made by Method Pharmaceuticals, LLC, principal owner

* Redhill Biopharma - Redhill expects to initiate promotion of Donnatal in Q2 of 2017

* Redhill Biopharma - court awarded Concordia treble damages of $2.2 million, an increase from original damages award of $733,000

* Redhill Biopharma - in Jan, co announced co-promotion agreement with unit of Concordia, granting co certain promotional rights in U.S. for Donnatal Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐